The Role of Na+/H+ Exchange and Growth Factors in Pulmonary Artery Smooth Muscle Cell Proliferation

American Journal of Respiratory Cell and Molecular Biology

Volumn 14, Issue 2, 1996, Pages 139-145

  Quinn, Deborah A ^b   Dahlberg, Carl G W ^b   Bonventre, Joseph P ^b   Scheid, Cheryl R ^b   Honeyman, Tom ^b   Joseph, Patricia M ^b   Thompson, B Taylor ^b   Hales, Charles A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 DIMETHYLAMILORIDE; 5-DIMETHYLAMILORIDE; ALKALI; AMILORIDE; DRUG DERIVATIVE; EPIDERMAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SODIUM PROTON EXCHANGE PROTEIN;

ANIMAL; ARTICLE; CATTLE; CELL DIVISION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; PHYSIOLOGY; PULMONARY ARTERY; VASCULAR SMOOTH MUSCLE;

ALKALIES; AMILORIDE; ANIMALS; CATTLE; CELL DIVISION; EPIDERMAL GROWTH FACTOR; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; PULMONARY ARTERY; SODIUM-HYDROGEN ANTIPORTER;

EID: 0030077602     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.14.2.8630263     Document Type: Article

References (45)

1. Meyrick, B., and L. Reid. 1983. Pulmonary hypertension - anatomic and physiologic correlates. Clin. Chest Med. 4:199-217.
2. Hales, C. A. 1985. Pulmonary hypertension: vasoconstriction and vascular remodeling. Semin. Respir. Med. 7:136-140.
3. Hassoun, P. M., B. T. Thompson, D. Steigman, and C. A. Hales. 1989. Effect of heparin and warfarin on chronic hypoxic pulmonary hypertension and vascular remodeling in the guinea pig. Am. Rev. Respir. Dis. 139:763-768.
4. + exchange and growth factor-induced cytosolic pH changes. Role in cellular proliferation. Biochim. Biophys. Acta 988:73-97.
5. L'Allemain, G., S. Paris, and J. Pouyssegur. 1984. Growth factor action and intracellular pH regulation in fibroblasts. J. Biol. Chem. 259:5809-5815.
6. + antiporter gene expression in vascular smooth muscle cells by hypertrophic and hyperplastic stimuli. J. Biol. Chem. 265:19393-19396.
7. Castellot, J. J., L. A. Pukac, L. C. Benjaman, T. C. Wright, and M. J. Karnovsky. 1989. Heparin selectively inhibits a protein kinase C-dependent mechanism in cell cycle progression in calf aortic smooth muscle cells. J. Cell Biol. 109:3147-3155.
8. + influx in vascular smooth muscle cells. Am. J. Physiol. 247:C501-C505.
9. Kourembanas, S., R. L. Hannan, and D. V. Faller. 1990. Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. J. Clin. Invest. 86:670-674.
10. Joseph, P. M., B. T. Thompson, and C. A. Hales. 1990. Effect of hypoxia on the secretion of platelet derived growth factor by bovine pulmonary artery endothelial cells. FASEB J. 4(3)Part I:A346.
11. Katayose, D., M. Ohe, K. Yamauchi, M. Ogata, R. Shirato, H. Fuita, S. Shibahara, and T. Takishima. 1993. Increased expression of PDGF A- and B-chain genes in rat lungs with hypoxic pulmonary hypertension Am. J. Physiol. 264:L100-L106.
12. Oka, T., and D. N. Orth. 1983. Human plasma epidermal growth factor/B-urogastrone is associated with blood platelets. J. Clin. Invest. 72:249-258.
13. Ross, R. 1986. The pathogenesis of artherosclerosis - an update. N. Engl. J. Med. 314:488-500.
14. Sannes, P. L., K. K. Burch, and J. Khosla. 1992. Immunohistochemical localization of epidermal growth factor and acidic and basic fibroblast growth factors in postnatal developing and adult rat lungs Am. J. Respir. Cell Mol. Biol. 7:230-237.
15. + exchange in pulmonary artery smooth muscle from spontaneously hypertensive rats and Wistar Kyoto rats. Am. J. Physiol. 269 (Lung Cell Mol. Physiol. 13):L673-L680.
16. Yu, F. S. S., S. L. Lee, J. J. Lanzillo, and B. L. Fanburg. 1989. Endothelial cell inhibition of hypoxia-induced stimulation of serotonin up-take by vascular smooth muscle cells. Am. Rev. Respir. Dis. 138:1144-1148.
17. Ross, R. 1971. Growth of smooth muscle cells in culture and formation of elastic fibers. J. Cell Biol. 197:172-186.
18. McGuire, P. G., and R. W. Orkin. 1987. Isolation of rat aortic endothelial cells by primary expiant techniques and their phenotypic modulation by defined substrata. Lab. Invest. 57:94-104.
19. + exchange to pH regulation in pulmonary artery smooth muscle cells. Am. J Respir. Cell Mol. Biol. 5:586-591.
20. Thomas, J. A., R. N. Buchsbaum, A. Zimniak, and E. Racker. 1979. Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 81:2210-2218.
21. 3, and metabolic inhibitors. J. Gen. Physiol. 67:91-112.
22. 3. Am. J. Physiol. 259:C471-C483.
23. + exchange in cultured vascular smooth muscle cells. J. Biol. Chem. 262:5057-5064.
24. Counilion, L., and J. Pouyssegur. 1995. Structure function studies and molecular regulation of the growth factor activatable sodium-hydrogen exchanger (NHE-1). Cardiovasc. Res. 29:147-154.
25. Seifter, J. L., and P. S. Aronson. 1986. Properties and physiologic roles of the plasma membrane sodium-hydrogen exchanger. J. Clin. Invest. 78:859-864.
26. Kleyman, T. R., and E. J. Cragoe. 1988. Amiloride and its analogs as tools in study of ion transport. J. Membr. Biol. 105:1-21.
27. Bagby, S. P., M. M. O'Reilly, E. A. Kirk, L. H. Mitchell, P. E. Stenberg, M. T. Makler, and A. C. Bakke. 1992. EGF is incomplete mitogen in porcine aortic smooth muscle cells: DNA synthesis without cell division. Am. J. Physiol. 262(Cell. Physiol. 31):C578-C588.
28. + exchange in normal NIH-3T3 cells and in NIH-3T3 cells expressing the ras oncogene. Am. J. Physiol. 256:C756-C763.
29. Lucchesi, P. A., and B. C. Berls. 1995. Regulation of sodium-hydrogen exchange in vascular smooth muscle. Cardiovasc. Res. 29:172-177.
30. + exchanger by PDGF and vanadate. Biochem. Biophys. Res. Commun. 145:111-117.
31. + antiporter in Chinese hamster embryo fibroblasts. J. Cell. Physiol. 132:311-317.
32. + antiporter activity by epidermal growth factor and insulin occurs without activation of protein kinase C. Biochem. Biophys. Res. Commun. 130:646-653.
33. + antiporter, a glycoprotein of 110 kD. Science 247:723-726.
34. Nishibe, S., M. I. Wahl, S. M. T. Hernadez-Sotomayor, N. K. Tonks, S. G. Rhee, and G. Carpenter. 1990. Increase of the catalytic activity of phospholipase C-yl by tyrosine phosphorylation. Science 250:1253-1256.
35. 2+ channel blockers inhibit the activation of recombinant platelet derived growth factor in vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA 86:2388-2392.
36. Chapron, Y., C. Cochet, S. Crouzy, T. Jullien, M. Keramidas, and J. Verdetti. 1989. Tyrosine protein kinase activity of the EGF receptor is required to induce activation of receptor-operated calcium channels. Biochem. Biophys. Res. Commun. 158:527-533.
37. Peppelenbosch, M. P., L. G. J. Tertoolen, and S. W. de Laat. 1991. Epidermal growth factor-activated calcium and potassium channels. J. Biol. Chem. 266:19938-19944.
38. + antiporter interactions. Am. J. Physiol. 261:C482-C489.
39. 2+. Am. J. Physiol. 259:C940-C948.
40. Bobik, A., A. Grooms, S. Grinpukel, and P. J. Little. 1988. The effects of alterations in membrane sodium transport on rat aortic smooth muscle proliferation. J. Hypertension 6:S219-S221.
41. Rothman, A., B. Wolner, D. Button, and P. Taylor. 1994. Immediate-early gene expression in response to hypertrophic and proliferative stimuli in pulmonary artery smooth muscle cells. J. Biol. Chem. 269:6399-6404.
42. + exchange and protein kinase C. J. Biol. Chem. 260:1155-1159.
43. Davis, R. J., and M. P. Czech. 1985. Amiloride directly inhibits growth factor receptor tyrosine kinase activity. J. Biol. Chem. 260:2543-2551.
44. + antiporter abolishes growth induced DNA synthesis in fibroblasts. J. Biol. Chem. 259:4313-4319.
45. Bobik, A., A. Grooms, P. J. Little, E. J. Cragoe, Jr., and S. Grinpukel. 1991. Ethylisopropylamiloride-sensitive pH control mechanisms modulate vascular smooth muscle growth. Am. J. Physiol. 260(Cell. Physiol. 29):C581-C588.